Literature DB >> 20307582

Neurochemical and behavioral effects elicited by bupropion and diethylpropion in rats.

Abel Santamaría1, Hugo R Arias.   

Abstract

This study is an attempt to demonstrate whether bupropion (BP) and diethylpropion (DEP) exert their pharmacological actions by similar neurochemical mechanisms in the dorsal striatum. In this regard, the release of dopamine (DA), glutamate (Glu), and GABA, was determined in the rat dorsal striatum after acute (5 min) and chronic (15 consecutive days) treatments, and subsequently correlated with the locomotor activities produced by these drugs. The results from the acute experiments indicate that BP and DEP (40 mg/kg) increase locomotor activity, whereas chronic DEP treatment decreases locomotor activity by unspecific mechanisms. Acute BP treatment produces significant DA and Glu, but not GABA, releases. A lesser extent of DA release and tissue content of DA and its metabolites, and consequently less locomotor activity, was observed after chronic BP treatment. Acute DEP (5mg/kg) was only able to slightly increase DA release and to decrease the tissue levels of DA, but no other markers, with practically nil locomotor activity, whereas chronic DEP produced even less neurotransmitter release. The observed difference between BP and DEP might be based on that although both drugs inhibit the DA and norepinephrine transporters, the BP-induced nicotinic receptor inhibition has yet to be demonstrated for DEP. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20307582     DOI: 10.1016/j.bbr.2010.03.023

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  15 in total

Review 1.  Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Psychopharmacology (Berl)       Date:  2010-07-08       Impact factor: 4.530

2.  Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-03-01       Impact factor: 4.530

3.  Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.

Authors:  Theodore Kazan; Christopher L Robison; Nicole Cova; Victoria M Madore; Sergios Charntikov
Journal:  Behav Brain Res       Date:  2020-02-25       Impact factor: 3.332

4.  Effects of bupropion on the ejaculatory response of male rats.

Authors:  M E Hueletl-Soto; M Carro-Juárez; G Rodríguez-Manzo
Journal:  Int J Impot Res       Date:  2014-05-01       Impact factor: 2.896

5.  Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine.

Authors:  Theodore Kazan; Sergios Charntikov
Journal:  Neuropharmacology       Date:  2019-01-03       Impact factor: 5.250

6.  The antidepressant bupropion exerts alleviating properties in an ovariectomized osteoporotic rat model.

Authors:  Hatem M Abuohashish; Mohammed M Ahmed; Salim S Al-Rejaie; Kamal E H Eltahir
Journal:  Acta Pharmacol Sin       Date:  2014-12-29       Impact factor: 6.150

Review 7.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

8.  A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.

Authors:  H Suplicy; C L Boguszewski; C M C dos Santos; M do Desterro de Figueiredo; D R Cunha; R Radominski
Journal:  Int J Obes (Lond)       Date:  2013-11-29       Impact factor: 5.095

9.  The involvement of mesolimbic dopamine system in cotinine self-administration in rats.

Authors:  Xiaoying Tan; Cynthia M Ingraham; William J McBride; Zheng-Ming Ding
Journal:  Behav Brain Res       Date:  2021-09-23       Impact factor: 3.332

10.  Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.

Authors:  Miguel M Carvalho; Filipa L Campos; Bárbara Coimbra; José M Pêgo; Carla Rodrigues; Rui Lima; Ana J Rodrigues; Nuno Sousa; António J Salgado
Journal:  Mol Neurodegener       Date:  2013-04-26       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.